---
title: "Propanc Biopharma Soars 47% During Regular Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291556495.md"
description: "Propanc Biopharma (PPCB) jumped 47% to $2.11 with 15.76M shares traded, showing sharp volatility within 5 minutes."
datetime: "2026-07-02T13:41:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291556495.md)
  - [en](https://longbridge.com/en/news/291556495.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291556495.md)
generator: "portal-rs"
---

# Propanc Biopharma Soars 47% During Regular Trading

Propanc Biopharma(PPCB.US) 盘中涨**46.53%**，现报**2.11 美元**。

### Related Stocks

- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)

## Related News & Research

- [Propanc Biopharma Announces Positive Preclinical Data For PRP In Pancreatic Cancer, Stock Soars](https://longbridge.com/en/news/297195775.md)
- [Propanc Biopharma says PRP cuts pancreatic tumor growth by over 90% in preclinical models](https://longbridge.com/en/news/297186353.md)
- [Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results](https://longbridge.com/en/news/297207596.md)
- [Propanc Biopharma plans first-in-human Phase 1b trial of PRP in up to 40 advanced solid tumor patients](https://longbridge.com/en/news/296229103.md)
- [Propanc Biopharma plans Phase 1b trial of PRP proenzyme therapy in advanced solid tumors in Q4](https://longbridge.com/en/news/295666144.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**